Home
Stock
AMPDF
Message Board
AMPD Ventures Inc Ordinary Shares (OTC: AMPDF) Read Post Read Post 800892 - Amazing This Board's So Quiet

NASDAQ: JBIO 1.71%

Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-? Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026

NASDAQ: UNCY 2.79%

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 2, 2026 in Unicycive Therapeutics, Inc. Lawsuit - UNCY

NYSE: GDDY 2.07%

Kaplan Fox Encourages GoDaddy Inc. (GDDY) Investors Who Suffered Losses to Seek a Leadership Role Before October 20, 2026

NASDAQ: SGMT 7.91%

Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

NYSE: LB 1.66%

Highlight Therapeutics Presents Positive Phase 2b Topline Results of Intralesional BO-112 in Localized Basal Cell Carcinoma as a Late-Breaker at EADV

NASDAQ: VBIO 12.33%

Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity

NASDAQ: JBIO 2.79%

Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-? Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026

NASDAQ: UNCY 2.79%

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 2, 2026 in Unicycive Therapeutics, Inc. Lawsuit - UNCY

NASDAQ: GDDY 2.79%

Kaplan Fox Encourages GoDaddy Inc. (GDDY) Investors Who Suffered Losses to Seek a Leadership Role Before October 20, 2026

NASDAQ: SGMT 2.79%

Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

NASDAQ: LB 2.79%

Highlight Therapeutics Presents Positive Phase 2b Topline Results of Intralesional BO-112 in Localized Basal Cell Carcinoma as a Late-Breaker at EADV

NASDAQ: VBIO 2.79%

Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity

AMPDF

Quote

Short

News

Articles

Message Board

AMPD Ventures Inc Ordinary Shares (OTC: AMPDF Message Board Post 800892

Recent AMPDF Posts

Posted By: (investorshub) @TechnicalAnalyst1984

Posted on: Sep/23/2021 23:35:16

Amazing this board's so quiet

Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166059011

Back to AMPDF Board

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Email address

Mobile

I accept the terms of service

Message Board Posts

Recent AMPDF Posts

August 26, 2021 05:09:52 pm

investorshub : TechnicalAnalyst1984

In at .29 today; could have been .25

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Schedule a 30 minute Brand Awareness meeting with Market Wire News

Schedule a 30 minute Brand Awareness meeting with Market Wire News.

Schedule a Meeting

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.

Trending Stocks